MedRhythms is a digital therapeutics company that uses sensors, music, and software to build evidence-based, neurologic interventions to measure and improve walking. Music has the ability to directly stimulate the brain to improve functional outcomes, and this principle underpins the science behind MedRhythms’ digital therapeutics. These therapeutics provide direct stimulation to enable the mechanism of action in each relevant population. For more information about how music directly stimulates the brain, visit the Scientific Approach page of our website: https://www.medrhythms.com/scientific-approach.
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $30.3M
Founded date: 2013
Investors 1
| Date | Name | Website |
| 26.11.2021 | Global Bra... | globalbrai... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 28.07.2021 | Series B | $25M | - |
| 02.07.2018 | Series A | $5.3M | - |
Mentions in press and media 16
| Date | Title | Description |
| 29.08.2026 | Как песни могут помочь облегчить боль — и даже лечить симптомы инсульта | Учёные изучают, как нервная система синхронизируется с ритмом и звуком; это открывает новые возможности для неврологической помощи В документальном фильме 2014 года Alive Inside 94-летний Генри, житель дома престарелых, страдающий деменцией... |
| 05.05.2022 | Biogen and MedRhythms to Develop and Commercialize a Prescription Digital Therapeutic Targeting the Treatment of Gait Deficits in Multiple Sclerosis | The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS)MedRhythms to receive a $3 million upfront payment as part of the agreement and is eligible ... |
| 23.08.2021 | MedRhythms Co-founder and CEO Brian Harris on VatorNews podcast | Neurologic music therapy is a new digital therapeutic to improve activities, like walking Vator · VatorNews Podcast with Brian Harris, Co-founder and CEO of MedRhythms Bambi Francisco Roizen interviews MedRhythms Co-founder and CEO Brian Ha... |
| 28.07.2021 | MedRhythms : Closes $25M Series B Funding Led by Morningside Ventures and Advantage Capital to Advance Digital Therapeutics Platform | MedRhythms, a leader in developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, announced today the closing of a $25 million Series ... |
| 28.07.2021 | TPG and Brookfield add billions to the climate-tech coffers | As interest in climate-tech grows, so are the mega war chests. Paid Content Building a world economy in WordPress From WP Engine Growth equity and buyout investor TPG announced earlier this week that it had raised $5.4 billion to invest in ... |
| 28.07.2021 | TPG and Brookfield add billions to the climate-tech coffers | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. As interest in climate-tech grows, so are the mega war chests. Growth equity and buyout investor ... |
| 28.07.2021 | MedRhythms Raises $25M in Series B Funding | MedRhythms, a Portland, Maine-based developer of prescription digital therapeutics, closed a $25m Series B financing round. The round was co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth ... |
| 28.07.2021 | MedRhythms Closes $25M Series B Funding Led by Morningside Ventures and Advantage Capital to Advance Digital Therapeutics Platform | All the sessions from Transform 2021 are available on-demand now. Watch now. – Series B Financing will Catalyze Growth and Commercialization of Chronic Stroke Digital Therapeutic and Advance Pipeline PORTLAND, Maine–(BUSINESS WIRE)–July 28,... |
| 28.07.2021 | MedRhythms raises $25M to get patients back in tune after a stroke | MedRhythms secured $25 million in Series B funding to advance its digital therapy platform aimed at measuring and improving someone’s ability to walk after they have experienced a neurologic injury or disease. Morningside Ventures and Advan... |
| 18.05.2021 | MedRhythms, Massachusetts General Hospital Collaborate on Neuroimaging Study in Multiple Sclerosis |
Show more